Molecular essence and treatment strategy of ER-negative/PgR-positive/HER2erhyphen;negative breast cancer

被引：0
|
作者：
Yu, K.
Shao, Z.
机构：
[1] Fudan Univ, Shanghai Med Coll, Ctr Canc, Dept Breast Surg, Shanghai 200433, Peoples R China
[2] Fudan Univ, Shanghai Med Coll, Inst Canc, Shanghai 200433, Peoples R China
来源：
BREAST | 2015年 / 24卷
关键词：
D O I：
10.1016/S0960-9776(15)70161-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P119
引用
收藏
页码：S65 / S66
页数：2
相关论文
共 50 条
  • [21] COX-2 activation is associated with Akt phosphorylation and poor survival in ER-negative, HER2-positive breast cancer
    Sharon A Glynn
    Robyn L Prueitt
    Lisa A Ridnour
    Brenda J Boersma
    Tiffany M Dorsey
    David A Wink
    Julie E Goodman
    Harris G Yfantis
    Dong H Lee
    Stefan Ambs
    BMC Cancer, 10
  • [22] Is there any association between a delay in surgery and nodal positivity in the ER-negative Her2 negative breast cancer subgroups?
    Altundag, Kadri
    JOURNAL OF SURGICAL ONCOLOGY, 2021, 124 (01) : 154 - 154
  • [23] Interleukin-8 in progression of ER-positive and ER-negative breast cancer patients
    Todorovic-Rakovic, N.
    Milovanovic, J.
    Abu Rabi, Z.
    EUROPEAN JOURNAL OF CANCER, 2016, 57 : S115 - S115
  • [24] Apocrine metaplasia and the development of ER-negative breast cancer
    Lee, S
    Mohsin, SK
    Weiss, H
    Medina, D
    Allred, DC
    LABORATORY INVESTIGATION, 2005, 85 : 40A - 40A
  • [25] The Molecular Anatomy of Breast Cancer Stroma; Independent Prognostic Role in ER-Positive and ER-Negative Cancers.
    Bianchini, G.
    Alvarez, R. H.
    Qi, Y.
    Hatzis, C.
    Iwamoto, T.
    Shiang, C.
    Coutant, C.
    Hortobagyi, G. N.
    Symmans, W. F.
    Pusztai, L.
    CANCER RESEARCH, 2009, 69 (24) : 507S - 507S
  • [26] Apocrine metaplasia and the development of ER-negative breast cancer
    Lee, S
    Mohsin, SK
    Weiss, H
    Medina, D
    Allred, DC
    MODERN PATHOLOGY, 2005, 18 : 40A - 40A
  • [27] Apocrine metaplasia and the development of ER-negative breast cancer
    Lee, S
    Weiss, H
    Tsimelzon, A
    Mao, S
    Wu, Y
    Mohsin, SK
    Medina, D
    Haagensen, DE
    Allred, DC
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S79 - S79
  • [28] Prognostic impact of PgR and Ki-67 expression in ER-positive and HER2-negative breast cancer patients
    Nishiyama, Yasuyuki
    Nishimura, Reiki
    Osako, Tomofumi
    Okumura, Yasuhiro
    Arima, Nobuyuki
    CANCER RESEARCH, 2015, 75
  • [29] A new estrogen receptor on ER-negative breast cancer?
    Peralta, E.
    Paris, B. D.
    Kamel, O. W.
    Louis, S.
    Dunnington, G. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [30] DNA methylation landscapes in ER-negative breast cancer
    Worsham, M. J.
    Chen, K. M.
    Chitale, D.
    Divine, G.
    CANCER RESEARCH, 2012, 72
12345